0460 Share Price

Open 2.23 Change Price %
High 2.24 1 Day -0.02 -0.90
Low 2.17 1 Week 0.09 4.29
Close 2.19 1 Month 0.32 17.11
Volume 28167418 1 Year -2.24 -50.56
52 Week High 2.60
52 Week Low 1.41
0460 Important Levels
Resistance 2 2.25
Resistance 1 2.23
Pivot 2.20
Support 1 2.15
Support 2 2.13
HKG HongKong Most Active Stocks
0261 0.01 0.00%
0566 3.91 0.00%
0136 0.59 -4.84%
0459 0.05 25.00%
8171 0.02 0.00%
0061 0.02 0.00%
0395 0.16 -5.88%
0981 1.03 0.00%
0997 0.04 0.00%
2324 0.06 0.00%
More..
HKG HongKong Top Gainers Stocks
0459 0.05 25.00%
8048 0.14 16.67%
1386 1.63 15.60%
0007 0.78 14.71%
0685 1.29 14.16%
0149 1.19 13.33%
0602 0.52 13.04%
8148 0.18 12.50%
0500 1.17 12.50%
0660 0.09 12.50%
More..
HKG HongKong Top Losers Stocks
8165 0.08 -27.27%
0274 0.03 -25.00%
4333 60.00 -25.00%
8002 4.00 -15.97%
2369 0.70 -12.50%
1094 0.07 -12.50%
8190 0.14 -12.50%
1192 0.08 -11.11%
1191 0.25 -10.71%
8051 0.67 -10.67%
More..

Sihuan Pharmaceutical (HKG: 0460)

0460 Technical Analysis 2
As on 7th Dec 2016 0460 Share Price closed @ 2.19 and we RECOMMEND Sell for LONG-TERM with Stoploss of 2.31 & Strong Buy for SHORT-TERM with Stoploss of 1.87 we also expect STOCK to react on Following IMPORTANT LEVELS.
0460 Target for December
1st Target up-side 2.26
2nd Target up-side 2.37
3rd Target up-side 2.48
1st Target down-side 1.94
2nd Target down-side 1.83
3rd Target down-side 1.72
0460 Other Details
Segment EQ
Market Capital 0.00
Sector Healthcare
Industry Drugs - Generic
Offical website http://www.sihuanpharm.com
0460 Address
0460
Zhubang 2000 Business Centre
Building 2, 21st Floor
Beijing, 10025
China
Phone: 86 10 5227 8700
Fax: 86 10 5227 8758
0460 Latest News
Interactive Technical Analysis Chart Sihuan Pharmaceutical ( 0460 HKG HongKong )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Sihuan Pharmaceutical
0460 Business Profile
Sihuan Pharmaceutical Holdings Group Ltd., an investment holding company, researches and develops, manufactures, and sells pharmaceutical products in the People’s Republic of China. The company offers various cardio-cerebral vascular drugs, such as Oudimei to treat dysfunction caused by cardiac and brain diseases; Kelinao/Anjieli/Qingtong to treat cardio, cerebro, and peripheral vascular diseases; Yuanzhijiu to treat cardio-cerebral vascular diseases; GM1 to treat traumatic brain injuries, cerebral vascular accidents, and Parkinson’s disease; Guhong to treat cerebrovascular problems; and Yimaining to treat chronic arteriosclerosis obliterans, unstable angina, myocardial infarction, coronary artery bypass surgery, cerebral infarction, ischemic spinal cord injury, diabetes, peripheral neuropathy, diabetes, and kidney diseases. It also offers Qu’Ao to treat brain cell dysfunction; Yeduojia primarily for peripheral nerve injuries; Chuanqing to treat ischemic cerebrovascular and coronary heart disease, cerebral embolism, vasculitis, and vascular dementia; Qu’Ao to treat brain cell dysfunction, traumatic brain injuries, and Alzheimer’s disease; and Danshen Chuanxiongqin to treat occlusive cerebrovascular diseases. In addition, the company provides Ren’Ao, a central nervous system drug; Luoanming, a metabolism drug; Bi’Ao and Zhuo’Ao to treat acute chronic respiratory diseases and to prevent lung infections after surgery; and Pojia, an anti-infective drug. Further, it is engaged in the further processing of agricultural and sideline products; construction of medical projects; and sale of medical appliances and supplies. The company distributes its products through a network of distributors and their sales force to hospitals and physicians. Sihuan Pharmaceutical Holdings Group Ltd. was founded in 2001 and is headquartered in Beijing, the People’s Republic of China.